Spark Therapeutics
UEI: FQ9CFQFD6MP6
• CAGE: 7CUR0
Overview
Parent Awardee
Company Description
Spark Therapeutics is challenging the inevitability of genetic disease by discovering, developing and delivering treatments in ways unimaginable – until now.
Name
Spark Therapeutics
Website
Headquarters
Philadelphia, PA
United States
United States
Federal recipient
SPARK THERAPEUTICS, INC.
(UEI FQ9CFQFD6MP6, CAGE 7CUR0)
is headquartered in Philadelphia PA.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in March 2013 and
federally registered in
April 2015.
Federal Registration and Certifications
Legal Name
SPARK THERAPEUTICS, INC.
UEI
FQ9CFQFD6MP6
CAGE Code
7CUR0
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
March 13, 2013
Initial Registration
April 21, 2015
Last Registration
Feb. 10, 2025
Registration Activation
Jan. 30, 2025
Registration Expiration
Jan. 28, 2026
Fiscal Year End
December 31
Reported Entity Types
Foreign Owned
For Profit Organization
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Accepts Credit Cards
No
People
Vendor contacts at Spark Therapeutics
GSA Schedules and Price Lists
- Spark Therapeutics
- PoP: 4/14/19 - 4/14/26
- Type: Pharmaceuticals and Drugs (FSS 65 I B)